Therapy a Clinical Reality. Büning H, Wilson E, Bueren J, Schambach A, Auricchio A. Ther 2021;32(19-20):979-982 DOI: 10.1089/hum.2021.29183.hbu A first step toward in vivo gene editing in patients. Büning [...] 2020 Mar 31;17:666-682.doi: 10.1016/j.omtm.2020.03.016. eCollection 2020 Jun 12. Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future [...] 2022;14(2):427 DOI: 10.3390/cancers14020427 Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy. Meumann N, Cabanes-Creus M, Ertelt M, Navarro RG, Lucifora J, Yuan

Nabavi E, Wegner F; Distinct regional changes of brain glucose metabolism in patients with anti-NMDA and anti-LGI1 autoimmune encephalitis. European Conference on Clinical Neuroimaging. Lille 2014; OP035. Bruchmann [...] protection practice 2/2024, p. 4-45. Wanke C, Borowski M, Freudenberg R, Kühnel C, Kurth J, Militzer LC, Sattler B, Schütze C, Steffner M; Procedures for compliance with discharge criteria in patients after [...] medical personnel during clinical use of Lu-177-labeled radiopharmaceuticals. In: C. Streffer, C. Reiners, F. Fehringer, M. Froning (Eds.): Radiation Protection and Medicine: Patients - Employees - Society

Cardiovasc Care. 2020;9:173-182. https://pubmed.ncbi.nlm.nih.gov/29792513/ Akin M, Garcheva V, Sieweke JT, Flierl U, Daum HC, Bauersachs J, Schafer A. Early use of hemoadsorption in patients after out-of [...] room in patients with refractory out-of-hospital cardiac arrest. PLoS One. 2020;15:e0239777. https://pubmed.ncbi.nlm.nih.gov/32986781 Watson SA, Dendorfer A, Thum T, Perbellini F. A practical guide for [...] medication improve cardiac sympathetic nerve integrity? J Nucl Cardiol. 2020. https://pubmed.ncbi.nlm.nih.gov/32043241 Werner RA, Thackeray JT, Diekmann J, Weiberg D, Bauersachs J, Bengel FM. The changing face

Böttcher-Rebmann G*, Schell V, Cramer J, Artukarslan E, Baier C, Lenarz T, Salcher R. First clinical implementation of insertion force measurement in cochlear implantation surgery. Front Neurol. 2024; 15:1400455 [...] Sutharsan S, von Weihe S, WelteT, Wilken M, Rademacher J, Mertsch P. S2k guideline: Management of adult patients with bronchiectasis disease. AWMF registry number: 020-030, version 1.0. 2024 Ringshausen FC, Baumann [...] Sommerwerck U, Sutharsan S , von Weihe S, Welte T, Wilken M, Rademacher J, Mertsch P.Management of adult patients with bronchiectasis disease. An S2k guideline of the DGP. Pneumology. 2024; 78-833-899. Rühlemann

Hoeper MM, Scherag A, David S. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care 2018; 22(1):307. Schöttelndreier [...] characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease. Antimicrob Resist Infect Control 2018; 7:21. Baier C, Ipaktchi [...] Vogt PM. Universal decolonization with octenidine: First experiences in a tertiary burn intensive care unit. Burns Open 2019; 3(1):8-11. Baier C, Linderkamp C, Beilken A, Thol F, Heuser M, Ebadi E, Ga

Ernst D, Bange FC, Heiken H, Witte T, Schmidt RE, Stoll M. Improved prognosis of infection with M. genavense in immune compromized HIV patients after introduction of combined antiretroviral therapy. J Acquir [...] screening for vancomycin-resistant enterococci in hematologic and oncologic patients - findings of a German tertiary care center. J Glob Antimicrob Resist 2020; 2:102-105 Derer S*, Brethack AK*, Pietsch [...] costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. PLoS One 2020; 15(1):e0227772. Bange FC. Nocardia and other aerobic actinomycetes. In: Suerbaum

and scientific significance, the relevance and translation into clinical practice and the contribution of the submitted project to improving collaboration within nephrology institutions in Europe are evaluated [...] effects of cardiac FGF23 synthesis on pathological changes of the heart in mice in this session. Adriana Suhlrie also presented the results of her clinical doctoral thesis on proliferative lupus nephritis [...] two-day seminar is held to highlight clinical fields of activity and research in nephrology. The mentees can exchange ideas with fellow students and experts, receive clinical traineeship and PJ assistance and

(2009): Patient involvement in clinical ethics services: from access to participation and membership. Clin. Ethics 4(3): 146-151 Newson, A.J.; Neitzke, G. & Reiter-Theil, S. (2009): The role of patients in [...] (Rezension). EthikMed DOI: 10.1007/s00481-023-00780-8 Neitzke G (2023): The Role of Clinical Ethics Committees and Clinical Ethics Consultation. Journal of Hospital Ethics 9(2): 7 Agich G, Neitzke G, McCarthy [...] life: communication patterns in amyotrophic lateral sclerosis – a scoping review. Palliative Care & Social Practice 16: 1–18. DOI: 10.1177/26323524221083676 Persson K, Selter F, Kunzmann P & Neitzke G (2022):

a potential tool to improve peripheral nerve regeneration. ASNP-2015; Turin, Italy (April 9- 11, 2015) Haastert-Talini K. (German, 10.10.2014) Chitosan nerve splints: pre-clinical studies on the supportive [...] Raimondo S., Gambarotta G., Gnavi S. and Geuna S. The Neuregulin 1/ERBB System, a potential tool to improve peripheral nerve regeneration. ASNP-2015; Turin, Italy April 9- 11th, 2015 Pascal D., Tos P., Ronchi [...] ic descendent projections in the modulatory effects induced by treadmill exercise on the spinal changes that motoneurons suffer after peripheral nerve injury in rats. Assunção-Silva R. C., Costa-Oliveira

Kreipe H, Lehmann U: Molecular Analysis of Circulating Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection [...] Tolerance in Porcine Lung Transplantation: Modifications of the Preconditioning Regime for Improved Clinical Feasibility. Transplant Direct 2017; 3(7): e170 Kampers J, Orjuela-Grimm M, Schober T, Schulz [...] Wuerstlein R, Kreipe HH , Harbeck N: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomized phase 3 West